Healthcare Innovations, 10

Back to All Secondary Trusts

Portfolio Holdings by Security (As of Deposit Date)

  • Ticker
    Security Description
    Deposit %
  • ACAD
    ACADIA Pharmaceuticals Inc.
    3.32
  • APLS
    Apellis Pharmaceuticals, Inc.
    3.41
  • AUPH
    Aurinia Pharmaceuticals Inc.
    3.27
  • AXSM
    Axsome Therapeutics, Inc.
    3.32
  • BHVN
    Biohaven Pharmaceutical Holding Company Ltd.
    3.34
  • CHRS
    Coherus BioSciences, Inc.
    3.36
  • CRTX
    Cortexyme, Inc.
    3.35
  • DCPH
    Deciphera Pharmaceuticals, Inc.
    3.33
  • ENTA
    Enanta Pharmaceuticals, Inc.
    3.32
  • EPZM
    Epizyme, Inc.
    3.35
  • GBT
    Global Blood Therapeutics, Inc.
    3.36
  • GWPH
    GW Pharmaceuticals plc
    3.31
  • HRTX
    Heron Therapeutics, Inc.
    3.34
  • ICPT
    Intercept Pharmaceuticals, Inc.
    3.33
  • INSM
    Insmed Incorporated
    3.31
  • KPTI
    Karyopharm Therapeutics Inc.
    3.18
  • MDGL
    Madrigal Pharmaceuticals, Inc.
    3.34
  • MESO
    Mesoblast Limited
    3.30
  • MRNA
    Moderna, Inc.
    3.36
  • MYOV
    Myovant Sciences Ltd.
    3.33
  • NGM
    NGM Biopharmaceuticals, Inc.
    3.35
  • NKTR
    Nektar Therapeutics
    3.31
  • QURE
    uniQure N.V.
    3.36
  • RETA
    Reata Pharmaceuticals, Inc.
    3.40
  • RVNC
    Revance Therapeutics, Inc.
    3.34
  • SAGE
    Sage Therapeutics, Inc.
    3.34
  • SUPN
    Supernus Pharmaceuticals, Inc.
    3.29
  • TGTX
    TG Therapeutics, Inc.
    3.32
  • UTHR
    United Therapeutics Corporation
    3.32
  • VIE
    Viela Bio, Inc.
    3.44

Health Care

  • Ticker
    Security Description
    Deposit %
  • ACAD
    ACADIA Pharmaceuticals Inc.
    3.32
  • APLS
    Apellis Pharmaceuticals, Inc.
    3.41
  • AUPH
    Aurinia Pharmaceuticals Inc.
    3.27
  • AXSM
    Axsome Therapeutics, Inc.
    3.32
  • BHVN
    Biohaven Pharmaceutical Holding Company Ltd.
    3.34
  • CHRS
    Coherus BioSciences, Inc.
    3.36
  • CRTX
    Cortexyme, Inc.
    3.35
  • DCPH
    Deciphera Pharmaceuticals, Inc.
    3.33
  • ENTA
    Enanta Pharmaceuticals, Inc.
    3.32
  • EPZM
    Epizyme, Inc.
    3.35
  • GBT
    Global Blood Therapeutics, Inc.
    3.36
  • GWPH
    GW Pharmaceuticals plc
    3.31
  • HRTX
    Heron Therapeutics, Inc.
    3.34
  • INSM
    Insmed Incorporated
    3.31
  • ICPT
    Intercept Pharmaceuticals, Inc.
    3.33
  • KPTI
    Karyopharm Therapeutics Inc.
    3.18
  • MDGL
    Madrigal Pharmaceuticals, Inc.
    3.34
  • MESO
    Mesoblast Limited
    3.30
  • MRNA
    Moderna, Inc.
    3.36
  • MYOV
    Myovant Sciences Ltd.
    3.33
  • NKTR
    Nektar Therapeutics
    3.31
  • NGM
    NGM Biopharmaceuticals, Inc.
    3.35
  • RETA
    Reata Pharmaceuticals, Inc.
    3.40
  • RVNC
    Revance Therapeutics, Inc.
    3.34
  • SAGE
    Sage Therapeutics, Inc.
    3.34
  • SUPN
    Supernus Pharmaceuticals, Inc.
    3.29
  • TGTX
    TG Therapeutics, Inc.
    3.32
  • QURE
    uniQure N.V.
    3.36
  • UTHR
    United Therapeutics Corporation
    3.32
  • VIE
    Viela Bio, Inc.
    3.44

Summary

Description

  • Trust Name

    Healthcare Innovations, 10

  • Trust Symbol

    SMHCJX

Deposit Data

  • Deposit Date

    11-04-2020

  • Termination Date

    11-04-2022

  • Minimum Investment

    100

  • Distribution Frequency

    Monthly (if any)

  • Initial Public Offer Price

    $10.00

  • Historical 12-Month Dist.*

    0.0000

CUSIP

  • Cash Cusip

    83192N509

  • Reinvest Cusip

    83192N517

  • Fee Cash Cusip

    83192N525

  • Fee Invest Cusip

    83192N533

*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.